Zydus Cadila's subsidiary to sell two brands, Mifegest and Cytolog

The said transaction is expected to be completed within 30 days from the date of execution of the agreement subject to customary approvals.

Sep 21, 2021 01:09 IST India Infoline News Service

Cadila Healthcare
Zydus Cadila's wholly-owned subsidiary, Zydus Healthcare has entered into an agreement with Integrace Private Limited (“Purchaser”) to sell two brands viz. Mifegest and Cytolog.

The said transaction is expected to be completed within 30 days from the date of execution of the agreement subject to customary approvals.

The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.

At around 1.57 pm, Cadila was trading at Rs547.65  per piece marginally up on Sensex. The stock has touched an intraday high and low of Rs550.95 per piece and Rs533.45 per piece respectively. 

Related Story

Open Free Demat Account (Rs699)